NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals

A Contract Award Notice
by NHS ENGLAND

Source
Contracts Finder
Type
Contract (Products)
Duration
2 year
Value
£305M
Sector
HEALTH
Published
06 Apr 2023
Delivery
01 May 2023 to 30 Apr 2025
Deadline
12 Dec 2022 13:00

Related Terms

Location

Geochart for 1 buyers and 50 suppliers

1 buyer

50 suppliers

Description

NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals Offer reference number: CM/PHR/22/5675 CM/PHR/22/5675/01 - NHS Framework Agreement for Branded Medicines - National Category Tender Lot 1. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines - National Tender Lot 2. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

Award Detail

1 Mercury Pharmaceuticals (London)
  • Value: £304,504,000
2 Gerot Lannach (Ely)
  • Value: £304,504,000
3 Bayer (Reading)
  • Value: £304,504,000
4 Aventis Pharma (Reading)
  • Value: £304,504,000
5 Tillomed Laboratories (Luton)
  • Value: £304,504,000
6 Sandoz (Camberley)
  • Value: £304,504,000
7 Pfizer (Sandwich)
  • Value: £304,504,000
8 Accord (Barnstaple)
  • Value: £304,504,000
9 Otsuka Pharmaceuticals (Wexham)
  • Value: £304,504,000
10 Morningside Pharmaeuticals (Northampton)
  • Value: £304,504,000
11 Astellas Pharma (Addlestone)
  • Value: £304,504,000
12 Wockhardt (Wrexham)
  • Value: £304,504,000
13 Lupin Healthcare (Slough)
  • Value: £304,504,000
14 Ipsen (Slough)
  • Value: £304,504,000
15 Mylan (Hatfield)
  • Value: £304,504,000
16 Neuraxpharm (Cardiff)
  • Value: £304,504,000
17 Ridge Pharma (Reading)
  • Value: £304,504,000
18 Ferring Pharmaceuticals (West Drayton)
  • Value: £304,504,000
19 Drugsrus (Northwood)
  • Value: £304,504,000
20 Medac Pharma (Stirling)
  • Value: £304,504,000
21 Kent Pharma (Ashford)
  • Value: £304,504,000
22 Martindale Pharma (Romford)
  • Value: £304,504,000
23 Janssen Cilag (Highwycombe)
  • Value: £304,504,000
24 Day Lewis Medical (Croydon)
  • Value: £304,504,000
25 Zentiva Pharma (London)
  • Value: £304,504,000
26 Teva (Castleford)
  • Value: £304,504,000
27 Glenmark Pharmaceuticals Europe (Watford)
  • Value: £304,504,000
28 Pharmasure (Watford)
  • Value: £304,504,000
29 Xiromed (Höllviken)
  • Value: £304,504,000
30 Recordati Rare Diseases (Bracknell)
  • Value: £304,504,000
31 Aspire Pharma (Godalming)
  • Value: £304,504,000
32 Chiesi (Manchester)
  • Value: £304,504,000
33 Selective Supplies (London)
  • Value: £304,504,000
34 Napp Pharmaceuticals (Cambridge)
  • Value: £304,504,000
35 Aspen Pharmacare (Central London)
  • Value: £304,504,000
36 Gedeon Richter (London)
  • Value: £304,504,000
37 Nordic Pharma (Theale)
  • Value: £304,504,000
38 Novartis Pharmaceuticals (London)
  • Value: £304,504,000
39 Synchrony (Stevenage)
  • Value: £304,504,000
40 Norgine Pharmaceuticals (Uxbridge)
  • Value: £304,504,000
41 Orifarm (Hemel Hempstead)
  • Value: £304,504,000
42 Qdem Pharmaceuticals (Cambridge)
  • Value: £304,504,000
43 Eli Lilly (Hants)
  • Value: £304,504,000
44 CST Pharma (Walsall)
  • Value: £304,504,000
45 Rovi Biotech (Croydon)
  • Value: £304,504,000
46 Merck Serono (Feltham)
  • Value: £304,504,000
47 Takeda (Kingdom Street London)
  • Value: £304,504,000
48 Tetris Pharma (Marlow)
  • Value: £304,504,000
49 Dexcel Pharma (Daventry)
  • Value: £304,504,000
50 Theramex HQ (London)
  • Value: £304,504,000

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Contract is suitable for SMEs.

Other Information

2022S 000-031803 - FTS Award Notice - CM_PHR_22_5675 Branded Medicines - National Proprietary Pharmaceuticals 2022S 000-031803 - FTS Award Notice - CM_PHR_22_5675 Branded Medicines - National Proprietary Pharmaceuticals.pdf Parties Appointed to the framework CM-PHR-22-5675 Parties Appointed to the framework CM-PHR-22-5675.xlsx 03 Framework Agreement and Terms and Conditions - CM_PHR_22_5675 03 Framework Agreement and Terms and Conditions - CM_PHR_22_5675.docx Transparency Award Schedule CM-PHR-22-5675-01 Transparency Award Schedule CM-PHR-22-5675-01.pdf Transparency Award Schedule CM-PHR-22-5675-02 Transparency Award Schedule CM-PHR-22-5675-02.pdf

Reference

  • CF-1454500D0O000000rwimUAA
  • CF 4df14586-94d9-4b98-adbf-f5a321e30282

Domains